"Concise industry news from the US pharmaceutical industry..."
New Account

The Magazine

Current Issue

You could argue that anything done in a new way, however small, can be counted as an innovation. Introducing innovation at a game-changing level, however, is not so simple, and it's only going to get harder for the pharmaceutical industry.

E-magazine
  • Previous Issues

Sponsors

Platinum Sponsors
Gold Sponsors
Silver Sponsors
Platinum Sponsors
Gold Sponsors
Silver Sponsors

Blog

Where our team of guest writers discuss what they think about the current NGP US Issues.

Peter Duncan
Director of Business Development

Can digital pathology save drug development?

Peter Duncan of Definiens discusses the potential of digital pathology.
07 Jul 2010
You need adobe flash player to view this content

Top Stories

Psychiatric drugs: a booming business

The top 25 psychiatric drugs of 2009, according to quantities of US prescriptions, have been published and the chart reveals that approximately 300 million prescriptions were written for these 25 medications during 2009...

Read more

Latest News

Editor’s Choice

Readers’ Choice

Executive Interviews

Centralized cardiac safety

How to achieve improved science at a lower cost with the most stakeholder convenience.
Read more

Stereology going mainstream

Lars Peterson discusses how whole slide stereology is beginning to make an impact in the biopharmaceutical industry.
Read more

Aspetic spray drying installation

The aseptic spray drying installation acquired by Hovione is the only one known to us that has successfully passed a FDA PAI (Pre-Approval Inspection).
Read more

Next Generation Healthcare Summit

Next Generation Healthcare Summit
25th - 27th October 2010

As healthcare costs continue to rise, health providers around the country feel a sharp sense of urgency in deploying information technology to lower costs, reduce medical errors, enhance outcomes, and spur efficiency in an industry known for legendary inefficiency.